Susquehanna International Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $802K | Buy |
35,483
+8,189
| +30% | +$182K | ﹤0.01% | 8467 |
|
|
2025
Q4 | $706K | Buy |
+27,294
| New | +$649K | ﹤0.01% | 8007 |
|
|
2025
Q3 | – | Sell |
-123,087
| Closed | -$3.02M | – | 13520 |
|
|
2025
Q2 | $2.94M | Sell |
123,087
-19,446
| -14% | -$490K | ﹤0.01% | 4997 |
|
|
2025
Q1 | $3.54M | Sell |
142,533
-43,887
| -24% | -$1.05M | ﹤0.01% | 4324 |
|
|
2024
Q4 | $3.51M | Buy |
186,420
+174,327
| +1,442% | +$3.06M | ﹤0.01% | 4168 |
|
|
2024
Q3 | $182K | Buy |
12,093
+1,271
| +12% | +$21.7K | ﹤0.01% | 10556 |
|
|
2024
Q2 | $310K | Sell |
10,822
-21,028
| -66% | -$598K | ﹤0.01% | 9371 |
|
|
2024
Q1 | $931K | Buy |
31,850
+17,360
| +120% | +$533K | ﹤0.01% | 7086 |
|
|
2023
Q4 | $489K | Sell |
14,490
-36,639
| -72% | -$1.07M | ﹤0.01% | 8718 |
|
|
2023
Q3 | $1.57M | Sell |
51,129
-7,220
| -12% | -$260K | ﹤0.01% | 5633 |
|
|
2023
Q2 | $2.34M | Sell |
58,349
-12,560
| -18% | -$519K | ﹤0.01% | 4841 |
|
|
2023
Q1 | $2.89M | Buy |
70,909
+65,614
| +1,239% | +$2.61M | ﹤0.01% | 4402 |
|
|
2022
Q4 | $204K | Sell |
5,295
-11,755
| -69% | -$572K | ﹤0.01% | 10071 |
|
|
2022
Q3 | $907K | Buy |
+17,050
| New | +$948K | ﹤0.01% | 6890 |
|
|
2022
Q2 | – | Sell |
-3,108
| Closed | -$204K | – | 13671 |
|
|
2022
Q1 | $237K | Sell |
3,108
-4,754
| -60% | -$317K | ﹤0.01% | 10832 |
|
|
2021
Q4 | $473K | Buy |
+7,862
| New | +$434K | ﹤0.01% | 9360 |
|
|
2021
Q3 | – | Sell |
-11,741
| Closed | -$677K | – | 13339 |
|
|
2021
Q2 | $712K | Buy |
11,741
+5,771
| +97% | +$365K | ﹤0.01% | 8700 |
|
|
2021
Q1 | $418K | Sell |
5,970
-16,894
| -74% | -$1.21M | ﹤0.01% | 9882 |
|
|
2020
Q4 | $1.37M | Sell |
22,864
-25,115
| -52% | -$1.47M | ﹤0.01% | 5958 |
|
|
2020
Q3 | $2.88M | Buy |
47,979
+41,897
| +689% | +$2.43M | ﹤0.01% | 3934 |
|
|
2020
Q2 | $319K | Sell |
6,082
-37,817
| -86% | -$1.58M | ﹤0.01% | 8251 |
|
|
2020
Q1 | $1.47M | Buy |
+43,899
| New | +$1.82M | ﹤0.01% | 4534 |
|
|
2019
Q4 | – | Sell |
-25,626
| Closed | -$1.09M | – | 10390 |
|
|
2019
Q3 | $976K | Sell |
25,626
-4,270
| -14% | -$170K | ﹤0.01% | 5747 |
|
|
2019
Q2 | $1.3M | Buy |
+29,896
| New | +$1.27M | ﹤0.01% | 5093 |
|
|
2019
Q1 | – | Sell |
-85,429
| Closed | -$3.33M | – | 9573 |
|
|
2018
Q4 | $3.67M | Buy |
85,429
+47,167
| +123% | +$2.2M | ﹤0.01% | 2648 |
|
|
2018
Q3 | $1.88M | Buy |
38,262
+26,507
| +225% | +$1.15M | ﹤0.01% | 4110 |
|
|
2018
Q2 | $377K | Buy |
+11,755
| New | +$406K | ﹤0.01% | 7389 |
|
|
2017
Q4 | – | Sell |
-102,025
| Closed | -$4.04M | – | 9734 |
|
|
2017
Q3 | $3.83M | Buy |
+102,025
| New | +$4.11M | ﹤0.01% | 2871 |
|
|
2017
Q1 | – | Sell |
-264,726
| Closed | -$11.4M | – | 9684 |
|
|
2016
Q4 | $8.55M | Buy |
264,726
+116,977
| +79% | +$3.9M | ﹤0.01% | 1710 |
|
|
2016
Q3 | $5.06M | Buy |
147,749
+88,879
| +151% | +$3.48M | ﹤0.01% | 2219 |
|
|
2016
Q2 | $1.99M | Buy |
58,870
+40,416
| +219% | +$1.99M | ﹤0.01% | 3585 |
|
|
2016
Q1 | $978K | Buy |
18,454
+12,196
| +195% | +$713K | ﹤0.01% | 5130 |
|
|
2015
Q4 | $481K | Sell |
6,258
-59,306
| -90% | -$3.36M | ﹤0.01% | 6841 |
|
|
2015
Q3 | $2.69M | Buy |
65,564
+53,583
| +447% | +$3.28M | ﹤0.01% | 3699 |
|
|
2015
Q2 | $847K | Sell |
11,981
-12,668
| -51% | -$998K | ﹤0.01% | 6566 |
|
|
2015
Q1 | $2.19M | Sell |
24,649
-6,186
| -20% | -$628K | ﹤0.01% | 4156 |
|
|
2014
Q4 | $2.73M | Sell |
30,835
-49,324
| -62% | -$4.67M | ﹤0.01% | 3887 |
|
|
2014
Q3 | $7.77M | Buy |
80,159
+20,636
| +35% | +$2.01M | ﹤0.01% | 2419 |
|
|
2014
Q2 | $5.47M | Buy |
59,523
+42,339
| +246% | +$3.22M | ﹤0.01% | 2927 |
|
|
2014
Q1 | $1.2M | Buy |
17,184
+2,315
| +16% | +$157K | ﹤0.01% | 5186 |
|
|
2013
Q4 | $855K | Buy |
+14,869
| New | +$782K | ﹤0.01% | 5768 |
|
|
2013
Q3 | – | Sell |
-12,456
| Closed | -$454K | – | 8665 |
|
|
2013
Q2 | $361K | Buy |
+12,456
| New | +$360K | ﹤0.01% | 6527 |
|
Other funds holding PCRX
DPCM
VPM
VCM
Susquehanna International Group's PCRX Position: Q1 2026 in Review
Susquehanna International Group increased its Pacira BioSciences (PCRX) stake by 30% in Q1 2026, buying an estimated $182K and bringing the position to 35,483 shares worth $802K. The position accounts for ﹤0.01% of the portfolio, ranked #8467.
Susquehanna International Group first reported a position in PCRX in Q2 2013 and has held it in 42 quarters since. The position peaked at $8.55M in Q4 2016. 241 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.
- Susquehanna International Group held 35,483 shares of Pacira BioSciences worth $802K as of Q1 2026.
- Susquehanna International Group bought 8,189 Pacira BioSciences shares in Q1 2026, an estimated $182K.
- Pacira BioSciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8467 holding.
- Susquehanna International Group first reported a position in Pacira BioSciences in Q2 2013 and has held it in 42 quarters since.
- Susquehanna International Group's Pacira BioSciences position peaked at $8.55M in Q4 2016.
- 241 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.